来自MSN17 天
KRYS Reports Upbeat Initial Data From Lung Cancer Study of KB707
Krystal Biotech KRYS announced encouraging initial clinical data from an early to mid-stage study of its investigational ...
Nasdaq19 天
Krystal Biotech Reports Positive Results for KYANITE-1 Study
Krystal Biotech announced positive initial clinical results from its KYANITE-1 study on inhaled KB707 for lung tumors, particularly showing monotherapy efficacy in advanced non-small cell lung ...